Correlation Between Oncopeptides and Alzinova

Can any of the company-specific risk be diversified away by investing in both Oncopeptides and Alzinova at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Oncopeptides and Alzinova into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Oncopeptides AB and Alzinova AB, you can compare the effects of market volatilities on Oncopeptides and Alzinova and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Oncopeptides with a short position of Alzinova. Check out your portfolio center. Please also check ongoing floating volatility patterns of Oncopeptides and Alzinova.

Diversification Opportunities for Oncopeptides and Alzinova

-0.38

Correlation Coefficient

Oncopeptides  Alzinova

Very good diversification

The 3 months correlation between Oncopeptides and Alzinova is -0.38. Overlapping area represents the amount of risk that can be diversified away by holding Oncopeptides AB and Alzinova AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Alzinova AB and Oncopeptides is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Oncopeptides AB are associated (or correlated) with Alzinova. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Alzinova AB has no effect on the direction of Oncopeptides i.e., Oncopeptides and Alzinova go up and down completely randomly.

Pair Corralation between Oncopeptides and Alzinova

Assuming the 90 days trading horizon Oncopeptides AB is expected to under-perform the Alzinova. In addition to that, Oncopeptides is 1.4 times more volatile than Alzinova AB. It trades about -0.13 of its total potential returns per unit of risk. Alzinova AB is currently generating about -0.04 per unit of volatility. If you would invest  360.00  in Alzinova AB on September 29, 2024 and sell it today you would lose (28.00) from holding Alzinova AB or give up 7.78% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	98.41%
Values	Daily Returns

Oncopeptides AB  vs.  Alzinova AB

Oncopeptides AB

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Oncopeptides AB has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in January 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Alzinova AB

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Alzinova AB has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Alzinova is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors.

Pair Trading with Oncopeptides and Alzinova

The main advantage of trading using opposite Oncopeptides and Alzinova positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Oncopeptides position performs unexpectedly, Alzinova can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Alzinova will offset losses from the drop in Alzinova's long position.

The idea behind Oncopeptides AB and Alzinova AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.